Emerging drugs in endometrial cancers
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728214.2010.517521
Reference59 articles.
1. Cancer Statistics, 2009
2. Treatment options for advanced endometrial carcinoma
3. Systemic therapy for recurrent endometrial cancer: a review of North American trials
4. Management of Advanced-Stage and Recurrent Endometrial Cancer
5. Management of Recurrent Endometrioid Endometrial Carcinoma: An Overview
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models;Cancers;2020-02-06
2. LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling Pathway;Pathology & Oncology Research;2019-10-24
3. A Molecular Carrier to Transport and Deliver Cisplatin into Endometrial Cancer Cells;Chemical Biology & Drug Design;2012-04-27
4. Current World Literature;Current Opinion in Oncology;2011-09
5. Antitumor Activity of Ridaforolimus and Potential Cell-Cycle Determinants of Sensitivity in Sarcoma and Endometrial Cancer Models;Molecular Cancer Therapeutics;2011-08-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3